EUVIMEDEUVIMED entdecken
Open Access

Digital Antibiotic Allergy Decision Support Tool Improves Management of β-Lactam Allergies

Theresa B Dunham, Rebecca M Gardner, Elizabeth A Lippner, Danielle E Fasani, Elwyn Moir, Bonnie Halpern-Felsher, Vandana Sundaram, Anne Y Liu

The Journal of Allergy and Clinical Immunology: In Practice · 2023

DOI: 10.1016/j.jaip.2023.01.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Theresa B Dunham und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif. Electronic addr…. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Hypersensitivity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, STANFORD UNIVERSITY SCHOOL OF MEDICINE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Frontline providers frequently make time-sensitive antibiotic choices, but many feel poorly equipped to handle antibiotic allergies. OBJECTIVE: We hypothesized that a digital decision support tool could improve antibiotic selection and confidence when managing β-lactam allergies. METHODS: A digital decision support tool was designed to guide non-allergist providers in managing patients with β-lactam allergy labels. Non-allergists were asked to make decisions in clinical test cases without the tool, and then with it. These decisions were compared using paired t tests. Users also completed surveys assessing their confidence in managing antibiotic allergies. RESULTS: The tool's algorithm was validated by confirming its recommendations aligned with that of five allergists. Non-allergist providers (n = 102) made antibiotic management decisions in test cases, both with and without the tool. Use of the tool increased the proportion of correct decisions from 0.41 to 0.67, a difference of 0.26 (95% CI, 0.22-0.30; P < .001). Users were more likely to give full-dose antibiotics in low-risk situations, give challenge doses in medium-risk situations, and avoid the antibiotic and/or consult allergy departments in high-risk situations. A total of 98 users (96%) said the tool would increase their confidence when choosing antibiotics for patients with allergies. CONCLUSIONS: A point-of-care clinical decision tool provides allergist-designed guidance for non-allergists and is a scalable system for addressing antibiotic allergies, irrespective of allergist availability. This tool encouraged appropriate antibiotic use in low- and medium-risk situations and increased caution in high-risk situations. A digital support tool should be considered in quality improvement and antibiotic stewardship efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityHypersensitivityHumansbeta-LactamsAnti-Bacterial AgentsSurveys and QuestionnairesPenicillins

Stichwörter der Autor:innen

Antibiotic allergyDigital toolPenicillin allergyβ-Lactam allergy

Substanzen

beta-LactamsAnti-Bacterial AgentsPenicillins

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif. Electronic address: theresa.dunham24@gmail.com.
  • Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, Calif.
  • Division of Allergy and Immunology, Department of Pediatrics, Anne and Robert H. Lurie Children's Hospital and Northwestern Feinberg School of Medicine, Chicago, Ill.
  • Department of Pharmacy, Stanford Health Care, Stanford, Calif.
  • Clinical Observation and Medical Transcription Program, Stanford, Calif.
  • Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, Calif.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • STANFORD UNIVERSITY SCHOOL OF MEDICINE
  • National Institutes of Health
  • National Heart Lung and Blood Institute
  • National Center for Research Resources
  • National Center for Advancing Translational Sciences

Zitieren

APA

Dunham, T. B., Gardner, R. M., Lippner, E. A., Fasani, D. E., Moir, E., Halpern-Felsher, B., Sundaram, V., & Liu, A. Y. (2023). Digital Antibiotic Allergy Decision Support Tool Improves Management of β-Lactam Allergies. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.01.026

Vancouver

Dunham TB, Gardner RM, Lippner EA, Fasani DE, Moir E, Halpern-Felsher B, et al. Digital Antibiotic Allergy Decision Support Tool Improves Management of β-Lactam Allergies. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.01.026

BibTeX
@article{Dunham2023,
  author = {Dunham, Theresa B and Gardner, Rebecca M and Lippner, Elizabeth A and Fasani, Danielle E and Moir, Elwyn and Halpern-Felsher, Bonnie and Sundaram, Vandana and Liu, Anne Y},
  title = {Digital Antibiotic Allergy Decision Support Tool Improves Management of β-Lactam Allergies},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  doi = {10.1016/j.jaip.2023.01.026}
}
Kostenlos starten →